Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery

Clinical trial NCT07062952 · RECRUITING

Trial details

NCT number: NCT07062952
Sponsor: Jinling Hospital, China
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Kidney Tumors CKD Salt Substitute Nephrectomy eGFR

Start date: 2025-04-24
Primary completion: 2027-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.